Literature DB >> 24968739

Persistent postwithdrawal disorders induced by paroxetine, a selective serotonin reuptake inhibitor, and treated with specific cognitive behavioral therapy.

Carlotta Belaise1, Alessia Gatti, Virginie-Anne Chouinard, Guy Chouinard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24968739     DOI： 10.1159/000362317

Source DB:  PubMed          Journal:  Psychother Psychosom        ISSN： 0033-3190            Impact factor:   17.659


× No keyword cloud information.
  4 in total

Review 1.  Antidepressant Withdrawal and Rebound Phenomena.

Authors:  Jonathan Henssler; Andreas Heinz; Lasse Brandt; Tom Bschor
Journal:  Dtsch Arztebl Int       Date:  2019-05-17       Impact factor: 5.594

2.  The Efficacy of a Group CBT Relapse Prevention Program for Remitted Anxiety Disorder Patients Who Discontinue Antidepressant Medication: A Randomized Controlled Trial.

Authors:  Willemijn D Scholten; Neeltje M Batelaan; Patricia van Oppen; Johannes H Smit; Adriaan W Hoogendoorn; Harold J G M van Megen; Daniëlle C Cath; Anton J L M van Balkom
Journal:  Psychother Psychosom       Date:  2018-06-01       Impact factor: 17.659

3.  The pursuit of euthymia.

Authors:  Giovanni A Fava; Jenny Guidi
Journal:  World Psychiatry       Date:  2020-02       Impact factor: 49.548

Review 4.  Well-being Therapy in Depressive Disorders.

Authors:  Giovanni Mansueto; Fiammetta Cosci
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.